|
| |
BioPortfolio's Approved Drugs DatabaseAngiomaxBivalirudinDownload PDF containing detailed information.
Press Releases About Angiomax:
|
 |
| For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Company's Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro |
23rd April, 2009 |
Decision Resources |
Angiomax/Angiox Will Retain Decision Resources' Gold-Standard Status in 2017 for the Treatment of STEMI with Percutaneous Coronary Intervention, According to a New Report from Decision Resources
|
| Angiomax Will Retain Decision Resources' Proprietary Clinical Gold Standard Status Over Current and New Therapies, Including Recently-Approved Efient, for the Treatment of NSTEMI |
25th February, 2009 |
Decision Resources |
Angiomax Will Remain the NSTEMI Market Share Leader Through 2017, According to a New Report from Decision Resources
WALTHAM, Mass., Feb. 25 /PRNewswire/ -- Decision Resources, one of the world's
|
| Biotech Tracker: Profile of The Medicines Company |
1st January, 1970 |
Biotracker |
Biotech Tracker: Profile of The Medicines Company
August 13, 2003 The Medicines Company
|
| Biotech Tracker News - Key Angiomax Data Published in JAMA |
1st January, 1970 |
Biotracker |
Biotech Tracker News -
Key Angiomax Data Published in JAMA
|
| Novastan Plus ReoPro or Integrilin Promising for PCI Patients |
1st January, 1970 |
Biotracker |
Biotech Tracker News -
Novastan Plus ReoPro or Integrilin Promising for PCI Patients
|
Companies working in the area of Angiomax from Bioportfolio's Biocorporate database : | |
| Company Name | |
The Medicines Company was founded in 1996 to acquire, develop and commercialize selected pharmaceutical products in late stages of development and approved products. In December 2000, the Company...
www.themedicinescompany.com/ View full profile
| |
The Medicines Company was founded in 1996 to acquire, develop and commercialize selected pharmaceutical products in late stages of development and approved products. In December 2000, the Company...
www.themedicinescompany.com/ View full profile
| |
The Medicines Company meets the demands of the world's most advanced medical practitioners by developing products that improve acute hospital care. The Company markets Angiomax® (bivalirudin) for...
www.themedicinescompany.com/ View full profile
| | →View more Angiomax related companies. |
This page has been viewed 23 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Angiomax across BioPortfolio, or for Angiomax Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
